Explain what biological reductionism is, evaluate its strengths and limitations with evidence from several contexts, and compare it with holistic and biopsychosocial explanations of behaviour.
Each is in the Psychology glossary, with every other term in the subject.
Explaining a complex behaviour or mental process by breaking it down into its simplest biological parts, such as genes, neurotransmitters or brain areas.
A model proposed by Engel (1977) that explains health and illness through the interaction of biological, psychological and social factors rather than through biology alone.
A characteristic of a whole system that comes from the interaction of its parts and cannot be found in, or predicted from, any part on its own.
The mistaken belief that because a treatment relieves a condition, the condition must have been caused by a lack of what the treatment supplies or by the process it acts on.
Describe biological reductionism and the levels of explanation it works across.
Explain the difference between methodological and explanatory reductionism.
Evaluate the strengths of a biologically reductionist approach to studying behaviour.
Evaluate the limitations of biological reductionism, including the treatment–aetiology fallacy, interaction and determinism.
Compare and contrast biological reductionism with holism, interactionism and the biopsychosocial model.
Discuss the serotonin theory of depression as a test of a reductionist explanation.
Apply biological reductionism to explanations of behaviour in an unfamiliar scenario.
Biological reductionism is the attempt to explain complex behaviour by breaking it down into its simplest biological parts: genes, neurotransmitters, hormones and brain areas. The idea that depression is a “chemical imbalance” in the brain is a well-known example, and the debate about whether that idea is true shows both the power and the limits of reductionist thinking.
Reductionism is a question of perspective: it sets how a psychologist chooses to explain behaviour, what counts as evidence and which treatments seem sensible. It also raises questions of causality, because finding a biological difference in people with a disorder does not show that the difference caused it.
With a free account, Augment remembers where you stopped and what you have practiced.
Reductionism is the general strategy of explaining something complex by breaking it down into simpler parts. A car can be understood by studying its engine, wheels and brakes; a disease can be understood by studying the cells and chemicals involved. In psychology, reductionism means explaining a behaviour or mental process by the smaller units thought to make it up.
Reductionism can work at different levels. A behaviourist explains learning through simple stimulus–response links, and a cognitive psychologist may reduce memory to a set of stores and processes. Biological reductionism goes to the lowest level of all, and treats the biological parts as the real cause of the behaviour.
One useful way to think about reductionism is as a ladder of levels. The same behaviour, such as depression, can be explained at a social and cultural level (loss, poverty, stigma), a cognitive level (negative thoughts about the self and the future), a brain-systems level (activity in the prefrontal cortex and amygdala), a neurochemical level (serotonin, cortisol) and a genetic level. Lower levels describe smaller units, and biological reductionism explains the whole behaviour by the bottom rungs.
The opposite position is holism: the view that behaviour can only be understood by studying the whole person in their context, because the whole has properties that the parts do not have. Between the two lies interactionism, which accepts that each level contributes and studies how the levels influence each other.
It helps to separate two claims that are often mixed up. Methodological reductionism is a research strategy: to understand a complex system, study its parts one at a time, under controlled conditions. Most biological research is reductionist in this sense, and it is hard to see how science could progress without it.
Explanatory reductionism is a stronger claim: that a behaviour is nothing but the activity of its parts, so that once the biology is known, nothing more needs to be explained. Saying that love is “nothing but” dopamine and oxytocin, or that depression is “nothing but” low serotonin, is explanatory reductionism. Most criticisms of biological reductionism are aimed at this stronger claim.
Reductionist explanations appear in every context. The table gives one example from each, and shows what each explanation leaves out.
Context | Reductionist explanation | What it leaves out |
|---|---|---|
Health and well-being | Depression is caused by low levels of serotonin (the monoamine hypothesis). | Life events, thinking styles, social support, culture |
Human development | Adolescent risk-taking happens because the prefrontal cortex matures later than reward areas. | Peer influence, cultural norms about adolescence, opportunity |
Human relationships | Romantic love is the activity of dopamine and oxytocin in the reward system. | Shared values, communication, cultural ideas about marriage |
Learning and cognition | Memory is the strengthening of synapses in the hippocampus. | Meaning, schemas, motivation, how material is taught |
The biology in each of these explanations is supported by research. Each becomes reductionist when the biological level is treated as the whole explanation and the other levels are treated as unimportant or as mere effects of the biology.
A claim such as “people with depression have lower serotonin activity” can be tested by measuring serotonin, its breakdown products or its receptors, and the claim can be shown to be false. Higher-level explanations, such as “depression results from a loss of meaning”, are harder to operationalise and test. Reductionism therefore fits the scientific method well: it allows deductive research, in which a hypothesis is derived from a theory and tested against data.
Breaking a problem into parts also allows tight experimental controls. A researcher can change one neurotransmitter, for example by lowering serotonin through tryptophan depletion, and observe the effect on mood while holding other variables constant. This is how biological research tests causes rather than only correlations.
Reductionist research has produced treatments that help many people. Coppen (1967) proposed that depression is linked to reduced serotonin activity, part of what became the monoamine hypothesis, and this idea guided decades of drug development, including the selective serotonin reuptake inhibitors (SSRIs) prescribed today. Whatever their mechanism, antidepressants help a proportion of people with depression, especially severe depression.
The clearest success of biological reductionism is phenylketonuria (PKU), an inherited condition in which a single faulty gene prevents the body from breaking down phenylalanine, an amino acid in many foods. Untreated, it causes severe intellectual disability. Because the cause was traced to one gene and one chemical, newborn babies are now screened with a heel-prick blood test, and a special diet prevents the disability almost entirely.
Biological explanations present a disorder as an illness rather than a weakness of character. Campaigns against the stigma of mental illness have often used this message, on the reasoning that people are less likely to be blamed for a brain disorder than for a personal failing. As the limitations show, research suggests the effect is more complicated than this.
If a behaviour can be reduced to biological processes that humans share with other mammals, it can be studied in an animal model. Research on stress hormones in rats, for example, depends on the assumption that the relevant part of human stress can be reduced to a biological system that rats also have. This opens up experimental methods that are impossible with people, though it also brings the problems of extrapolating from animals.
The most common error in reductionist reasoning is to argue backwards from a treatment to a cause. If a drug that raises serotonin helps some people with depression, it is tempting to conclude that depression is caused by low serotonin. The same reasoning would conclude that headaches are caused by a lack of aspirin. This error is called the treatment–aetiology fallacy (aetiology means the cause of a disorder).
The size of the effect matters too. Kirsch et al. (2008) analysed all the trial data submitted to the United States Food and Drug Administration for four newer antidepressants, including unpublished trials. The difference between drug and placebo was small, close to zero in moderate depression, and reached conventional criteria for clinical significance only in the most severely depressed patients. Much of the improvement on the drugs also occurred on placebo, which is hard to explain if depression were simply a shortage of serotonin.
Many biological findings in psychology are correlations: people with depression differ on average in some brain measure from people without depression. A correlation cannot show which came first. Stress, poor sleep, inactivity and long-term medication can all change the brain, so a biological difference may be a result of the disorder or its treatment rather than its cause. This problem is called bidirectional ambiguity.
Moncrieff et al. (2022) found exactly this in serotonin research: some evidence of lower serotonin in people with depression was better explained by the fact that many of them had taken antidepressants for years.
Reductionism looks for one level, and often one cause. Research increasingly finds that biological factors matter mainly in interaction with environmental ones. Caspi et al. (2003) reported that people carrying one or two short versions of the serotonin transporter gene were more likely than people with two long versions to become depressed after many stressful life events, but not when life had been calm. The gene on its own predicted little; the gene combined with stress predicted more.
This particular interaction has since failed to replicate in very large samples, which is itself a warning about single-gene explanations. Wray et al. (2018), in a genome-wide association study of hundreds of thousands of people, identified 44 genetic variants linked to major depression, each with a very small effect. The genetic contribution to depression therefore comes from many genes of tiny effect acting together with life experience, rather than from a single “gene for depression”.
Some properties of a system exist only at the level of the whole. Wetness is a property of water, not of a single water molecule; a melody is a property of a sequence of notes, not of any one note. These are called emergent properties, and many psychological phenomena, such as meaning, identity, love and grief, may be emergent in this sense.
If a behaviour is emergent, describing its parts in more and more detail will not explain it. The grief of someone whose parent has died involves the brain, but it also involves the meaning of the relationship, the person’s memories and the rituals of their culture. A description of their cortisol levels and amygdala activity is accurate but leaves out what the grief is about.
Biological reductionism tends to treat the brain as the same everywhere, so it has little room for culture. Yet culture shapes how distress is experienced and expressed. Ryder et al. (2008) compared outpatients with depression in China (175 patients) and Canada (107 patients of European heritage). The Chinese patients reported more bodily symptoms, such as fatigue and pain, when describing their problems spontaneously and in a clinical interview, while the Euro-Canadian patients reported more psychological symptoms, such as sadness and guilt, on every measure.
The authors concluded that the Western focus on psychological symptoms may be the more culturally specific pattern. A purely biological explanation of depression cannot account for why the same disorder looks different in different cultures. Holistic models from other traditions, such as the Māori model of health Te Whare Tapa Whā, which treats physical, mental, family and spiritual well-being as four walls of one house, start from the whole person instead.
Strong biological reductionism tends towards biological determinism, the view that behaviour is fixed by biology and leaves little room for choice. This raises questions of responsibility: if a crime is explained by brain abnormalities, is the offender responsible? If depression is a fixed brain disorder, can a person do anything to recover?
Research suggests that biological explanations can have unintended costs. Lebowitz and Ahn (2014) gave US mental health clinicians descriptions of patients whose symptoms were explained either biologically or psychosocially. Biological explanations led the clinicians to feel significantly less empathy for the patients. Kemp, Lickel and Deacon (2014) gave adults with a history of depression a convincing but fake test result showing that their depression was, or was not, caused by a chemical imbalance. The chemical-imbalance result did not reduce self-blame, and it made participants more pessimistic about recovering.
These studies challenge the assumption that biological explanations reduce stigma. They suggest that presenting a disorder as a fixed fault in the brain may make people seem more different from others and recovery seem less possible, which is a reason for care in how biological findings are communicated to the public.
An interactionist explanation does not reject biology. It treats biological, cognitive and sociocultural factors as influencing one another, and asks how they combine. The diathesis–stress model, in which an inherited vulnerability leads to a disorder only when combined with environmental stress, is an interactionist model, and so is research on epigenetics, which shows that experience can change how genes are expressed.
The biopsychosocial model was proposed by the psychiatrist George Engel (1977) as a challenge to the “biomedical model”, which explained illness only through biology. Engel argued that to understand and treat a patient, a doctor must consider biological factors (genes, physiology), psychological factors (thoughts, emotions, coping) and social factors (family, work, culture, poverty) together, because they affect each other.
In depression, a biopsychosocial explanation might include a genetic vulnerability, a habit of negative thinking learned in childhood, and the loss of a job in a community with little social support, each making the others worse. Treatment may then combine medication, cognitive therapy and help with employment or relationships.
The model is widely taught in medicine and psychology, but it has limitations of its own. It describes which factors to consider rather than how they interact or which matters most in a given case, so it is hard to test and can become a list rather than an explanation.
Biological reductionism | Biopsychosocial model (holistic, interactionist) | |
|---|---|---|
Main claim | Behaviour is best explained by its biological parts | Behaviour results from interacting biological, psychological and social factors |
Typical methods | Laboratory experiments, brain imaging, genetics, animal research | Mixed methods: biological measures, questionnaires, interviews, longitudinal studies |
Strengths | Precise, testable, objective measurement, led to drug treatments | More complete, fits evidence on interaction and culture, guides combined treatment |
Limitations | Ignores interaction, emergence and culture; confuses treatment with cause; risks determinism and stigma | Vague about how factors interact; hard to test; can become a list |
View of treatment | Correct the biological fault, e.g. with medication | Combine biological, psychological and social interventions |
The two positions are often presented as opposites, but most researchers use both. Methodological reductionism is used to find out what each part does; an interactionist or biopsychosocial framework is then used to put the parts back together and explain the person.
YouTubeThe strengths and limitations do not lead to a simple verdict. Whether a biological explanation is adequate depends on the behaviour being explained and on the purpose of the explanation. A useful question to ask is at which level a change makes the biggest difference to the behaviour.
For some conditions, one biological level explains most of what matters. In PKU, the gene and the chemical explain the intellectual disability, and changing the diet prevents it. In Alzheimer’s disease, the loss of memory follows the death of neurons in the hippocampus and cortex, and psychological methods cannot reverse the damage. Here a reductionist explanation is close to complete, although social support still affects how patients and families cope.
For other behaviours, the biological level explains how the behaviour is carried out but not why it happens. Learning a second language involves changes in grey matter, but whether a child learns the language depends on schooling, family, migration and motivation. Prejudice involves the amygdala and other brain areas, but who is treated as an out-group depends on history and culture. In these cases the most useful explanations, and the most effective ways of changing the behaviour, are cognitive and sociocultural.
Many psychologists now take a position sometimes called explanatory pluralism: different levels answer different questions, and none is automatically the most basic. A biological explanation answers “what is happening in the brain when a person is depressed?”; a cognitive explanation answers “what thoughts keep the low mood going?”; a sociocultural explanation answers “why is depression more common in some groups than others?”. Each level can be tested by research, and the evidence from one level can check the claims of another.
The idea that depression is caused by low serotonin is the best-known biologically reductionist explanation in psychology. Moncrieff et al. (2022) tested it by gathering the strongest available evidence from each line of research in one review.
The researchers aimed to find out whether depression is associated with lower serotonin concentration or activity, by bringing together the main research on the question in a systematic umbrella review: a review of existing systematic reviews, meta-analyses and very large studies.
Two reviewers searched three research databases (PubMed, EMBASE and PsycINFO) from their start until December 2020, and judged the quality of each review using standard checklists. The review was registered in advance, which means its methods were published before the results were known. Studies of depression linked to physical illness and of bipolar depression were excluded.
Seventeen studies were included, covering six lines of evidence: serotonin and its breakdown product (5-HIAA) in blood and spinal fluid; serotonin 5-HT1A receptors; the serotonin transporter, measured by brain imaging or after death; tryptophan depletion, in which volunteers are given a drink that temporarily lowers serotonin; the serotonin transporter gene; and the interaction between that gene and stress.
Line of evidence | Largest sample in the evidence reviewed | Finding |
|---|---|---|
5-HIAA (a serotonin breakdown product) in body fluids | 1,002 | No association with depression |
Serotonin in blood plasma | 1,869 | No relationship with depression; lower levels linked to antidepressant use |
5-HT1A receptor binding | 561 | Weak evidence, if any, of differences |
Serotonin transporter binding | 1,845 | Weak and inconsistent; prior antidepressant use not reliably excluded |
Tryptophan depletion in volunteers | 566 healthy volunteers; 75 with a family history | No effect on mood in most volunteers; weak evidence of an effect with a family history of depression |
Serotonin transporter gene, and gene × stress | 115,257 (genetic study); 43,165 (collaborative meta-analysis) | No association with depression and no gene × stress interaction |
Sources: Moncrieff et al. (2022), umbrella review, as reported in the published abstract.
Across all six lines, the review found no consistent evidence of an association between serotonin and depression. Some evidence was consistent with the possibility that long-term antidepressant use lowers serotonin, which could explain why some earlier studies found lower levels in depressed patients.
The authors concluded that the main areas of serotonin research provide no consistent support for the hypothesis that depression is caused by lowered serotonin activity or concentration. They argued that the public should not be told that depression is caused by a chemical imbalance, because the evidence does not support it.
A strength of the review is that it looked at several independent methods of measuring serotonin, from body fluids to brain imaging, experiments and genetics. When different methods point the same way, the conclusion is more credible, which is a form of triangulation. A limitation is that serotonin in the brain cannot be measured directly in living people, so every line of evidence is indirect: blood levels, for example, may say little about serotonin at synapses in the brain.
The review was widely criticised. Jauhar et al. (2023), a group of 35 psychiatrists and neuroscientists, argued that its conclusions were overstated. They pointed to weaknesses in how the review was carried out, selective reporting of data, over-simplification and errors in interpreting the two most relevant kinds of research, tryptophan depletion and molecular imaging of the serotonin system.
Questions of possible bias were raised on both sides: the review’s lead author is a well-known critic of psychiatric drug treatment, and many of the critics declared payments from pharmaceutical companies, so the evidence itself has to be judged rather than the people presenting it. The debate itself shows how a reductionist claim can be tested and challenged in public.
The review weakens the claim that low serotonin causes depression, but it does not show that biology is irrelevant. Brain systems, stress hormones, inflammation and genetics are all still studied as parts of depression. What the review challenges is the reductionist step of explaining a complex disorder by one chemical, a step that went beyond the evidence for decades.
For many years the “chemical imbalance” explanation was used by doctors, drug advertisements and public campaigns, partly because it seemed to reduce blame. The review and the studies of empathy and prognosis by Lebowitz and Ahn and by Kemp et al. raise the question of whether scientists and clinicians acted responsibly in presenting a simple biological story with more certainty than the evidence allowed.
YouTubeSources: Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P. and Horowitz, M. A. (2022). The serotonin theory of depression: a systematic umbrella review of the evidence. _Molecular Psychiatry, 28(8), 3243–3256 (2023 print). Jauhar, S. et al. (2023). A leaky umbrella has little value. Molecular Psychiatry, 28(8), 3149–3152._
Biological reductionism is itself part of the concept of perspective, but evaluating it draws on all six concepts. The list gives the links that come up most often.
Perspective: reductionism and holism are different perspectives on what an explanation should look like; no single level gives a complete account.
Causality: reductionist research can test causes precisely, but it risks the treatment–aetiology fallacy and bidirectional ambiguity, and it underestimates interaction.
Measurement: biological variables can be measured objectively, but often only indirectly (serotonin in blood, not at the synapse), and some phenomena are emergent and cannot be measured at the biological level.
Bias: a preference for biological explanations is itself a bias, which can be reinforced by funding and by the appeal of simple stories; biological research is often carried out on WEIRD samples and overlooks culture.
Responsibility: biological explanations can increase stigma and pessimism, and raise questions about personal and legal responsibility for behaviour.
Change: reductionist research produced drug treatments that change behaviour; deterministic explanations may also make people believe change is impossible.
Biological reductionism is an approach term, so questions can ask for it on its own in Paper 1 Section A, or ask you to apply it to an unseen scenario in Paper 1 Section B. Because it is also part of the concept of perspective, it gives strong material for Section C essays, such as a claim that “one perspective is not enough to explain mental health”.
In Section B, the scenario usually contains a claim or a plan that is reductionist, or a situation that a reductionist explanation would only partly explain. The answer should keep returning to the details of the scenario.
Biological reductionism explains complex behaviour by its simplest biological parts: genes, neurotransmitters, hormones and brain areas.
Behaviour can be explained at several levels, from social and cultural to genetic; holism looks at the whole, and interactionism at how the levels affect each other.
Methodological reductionism (studying parts one at a time) is a useful research strategy; explanatory reductionism (“nothing but” claims) is the stronger claim most criticisms target.
Strengths: precise, testable hypotheses, controlled experiments, and effective treatments, with PKU as a clear success.
Limitations: the treatment–aetiology fallacy, bidirectional ambiguity, interaction between genes and environment, emergent properties, cultural blindness and determinism.
Biological explanations can reduce clinicians’ empathy and increase patients’ pessimism about recovery.
Moncrieff et al. (2022) found no consistent evidence that depression is caused by low serotonin; critics argued the review overstated its case.
The biopsychosocial model, proposed by Engel (1977), explains health and illness through interacting biological, psychological and social factors.
I can describe biological reductionism and the levels of explanation it works across.
I can explain the difference between methodological and explanatory reductionism.
I can evaluate the strengths of biological reductionism with examples.
I can evaluate its limitations, including the treatment–aetiology fallacy, interaction and determinism.
I can compare and contrast biological reductionism with holism and the biopsychosocial model.
I can discuss the serotonin theory of depression and the Moncrieff et al. review.
I can apply biological reductionism to an unfamiliar scenario.